Michael G Chez

Summary

Affiliation: California Pacific Medical Center
Country: USA

Publications

  1. pmc Safety and observations in a pilot study of lenalidomide for treatment in autism
    Michael Chez
    Sutter Neuroscience Medical Group, 1625 Stockton Boulevard, Suite 104, Sacramento, CA 95816, USA
    Autism Res Treat 2012:291601. 2012
  2. doi request reprint Immune therapy in autism: historical experience and future directions with immunomodulatory therapy
    Michael G Chez
    Pediatric Neurology and Autism Neurodevelopmental Program, Sutter Neuroscience Institute, Sacramento, California 95816, USA
    Neurotherapeutics 7:293-301. 2010
  3. ncbi request reprint Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children
    Michael G Chez
    Department of Neurology, Rosalind Franklin University, and the Chicago Medical School, North Chicago, IL, USA
    Pediatr Neurol 36:361-5. 2007
  4. ncbi request reprint Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability
    Michael G Chez
    Department of Neurology, Rosalind Franklin University The Chicago Medical School, Chicago, Illinois, USA
    J Child Neurol 22:574-9. 2007
  5. ncbi request reprint Neurologic treatment strategies in autism: an overview of medical intervention strategies
    Michael G Chez
    Department of Neurology, The Chicago Medical School, North Chicago, IL, USA
    Semin Pediatr Neurol 11:229-35. 2004
  6. ncbi request reprint Frequency of epileptiform EEG abnormalities in a sequential screening of autistic patients with no known clinical epilepsy from 1996 to 2005
    Michael G Chez
    Department of Neurology, Rosalind Franklin University of Health Sciences, Chicago Medical School, North Chicago, IL, USA
    Epilepsy Behav 8:267-71. 2006
  7. ncbi request reprint Immunizations, immunology, and autism
    Michael G Chez
    Department of Neurology, The Chicago Medical School, North Chicago, IL, USA
    Semin Pediatr Neurol 11:214-7. 2004
  8. ncbi request reprint Frequency of EEG abnormalities in age-matched siblings of autistic children with abnormal sleep EEG patterns
    Michael G Chez
    Autism and Epilepsy Specialty Services of Illinois, Ltd, Lake Bluff, IL, USA
    Epilepsy Behav 5:159-62. 2004
  9. ncbi request reprint Treating autistic spectrum disorders in children: utility of the cholinesterase inhibitor rivastigmine tartrate
    Michael G Chez
    Autism and Epilepsy Specialty Services of Illinois, Ltd, USA
    J Child Neurol 19:165-9. 2004
  10. ncbi request reprint Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders
    Michael G Chez
    Research Division, Autism and Epilepsy Specialty Services of Illinois, Ltd, Lake Bluff, IL 60044, USA
    J Child Neurol 17:833-7. 2002

Detail Information

Publications10

  1. pmc Safety and observations in a pilot study of lenalidomide for treatment in autism
    Michael Chez
    Sutter Neuroscience Medical Group, 1625 Stockton Boulevard, Suite 104, Sacramento, CA 95816, USA
    Autism Res Treat 2012:291601. 2012
    ..50 ± 68.92 to 40.25 ± 44.53 (P = 0.048). This study suggests that lenalidomide is tolerated as a treatment by children with autism and should be further studied as a potential agent for cytockine inflammation...
  2. doi request reprint Immune therapy in autism: historical experience and future directions with immunomodulatory therapy
    Michael G Chez
    Pediatric Neurology and Autism Neurodevelopmental Program, Sutter Neuroscience Institute, Sacramento, California 95816, USA
    Neurotherapeutics 7:293-301. 2010
    ..Historical immune interventions in autism are reviewed and potential new therapies and interventions are discussed...
  3. ncbi request reprint Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children
    Michael G Chez
    Department of Neurology, Rosalind Franklin University, and the Chicago Medical School, North Chicago, IL, USA
    Pediatr Neurol 36:361-5. 2007
    ..More controlled study of this potentially important observation may prove valuable...
  4. ncbi request reprint Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability
    Michael G Chez
    Department of Neurology, Rosalind Franklin University The Chicago Medical School, Chicago, Illinois, USA
    J Child Neurol 22:574-9. 2007
    ..Chronic use so far appears to have no serious side effects...
  5. ncbi request reprint Neurologic treatment strategies in autism: an overview of medical intervention strategies
    Michael G Chez
    Department of Neurology, The Chicago Medical School, North Chicago, IL, USA
    Semin Pediatr Neurol 11:229-35. 2004
    ..Future research into rational medical treatment options is desperately needed...
  6. ncbi request reprint Frequency of epileptiform EEG abnormalities in a sequential screening of autistic patients with no known clinical epilepsy from 1996 to 2005
    Michael G Chez
    Department of Neurology, Rosalind Franklin University of Health Sciences, Chicago Medical School, North Chicago, IL, USA
    Epilepsy Behav 8:267-71. 2006
    ..Of 176 patients treated with valproic acid, 80 normalized on EEG and 30 more showed EEG improvement compared with the first EEG (average of 10.1 months to repeat EEG)...
  7. ncbi request reprint Immunizations, immunology, and autism
    Michael G Chez
    Department of Neurology, The Chicago Medical School, North Chicago, IL, USA
    Semin Pediatr Neurol 11:214-7. 2004
    ..The goal of this article is to allow child neurologists to effectively counsel parents of autistic patients about vaccination risks and treatment options in presumed cases of autoimmune dysfunction...
  8. ncbi request reprint Frequency of EEG abnormalities in age-matched siblings of autistic children with abnormal sleep EEG patterns
    Michael G Chez
    Autism and Epilepsy Specialty Services of Illinois, Ltd, Lake Bluff, IL, USA
    Epilepsy Behav 5:159-62. 2004
    ..The lack of similarity between sibling EEGs suggests that genetic factors alone do not explain the higher frequency of EEG abnormalities reported in ASDs...
  9. ncbi request reprint Treating autistic spectrum disorders in children: utility of the cholinesterase inhibitor rivastigmine tartrate
    Michael G Chez
    Autism and Epilepsy Specialty Services of Illinois, Ltd, USA
    J Child Neurol 19:165-9. 2004
    ..These improvements were statistically significant and supported the hypothesis that treatment with cholinergic enhancing drugs in autistic spectrum disorders yields positive therapeutic effects...
  10. ncbi request reprint Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders
    Michael G Chez
    Research Division, Autism and Epilepsy Specialty Services of Illinois, Ltd, Lake Bluff, IL 60044, USA
    J Child Neurol 17:833-7. 2002
    ..05). Improved trends were noted on other outcome measures. Although the mechanism of action of L-carnosine is not well understood, it may enhance neurologic function, perhaps in the enterorhinal or temporal cortex...